Name: HCM Income Statement - Hutchmed (china) Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

HCM - Hutchmed (china) Ltd.

USD | NASDAQ | Healthcare

HCM Income Statement - Hutchmed (china) Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 19	Q1 FY 18
Revenues
Revenues	52.2	52.3
Cost of Revenue	-	-
Gross Profit	-	-
Operating Expenses
Research & Development	33.3	28.7
Selling General & Administrative	-	-
Selling & Marketing	-	-
General & Administrative	10.2	7.0
Depreciation & Amortization	1.2	0.8
Amortization of Intangibles	-	-
Other Operating Expenses	-	-
Total Operating Expenses	88.2	77.4
Operating Income
Operating Income	(36.1)	(25.0)
Non-Operating
Interest Income	1.7	1.3
Interest Expense	0.3	0.2
Income From Equity Investments	17.1	15.0
Other Non-Operating Income	1.1	1.2
Pre-Tax Income
Tax & Net
Income Tax Expense	1.3	1.6
Net Income From Continuing Ops	(19.1)	(10.4)
Net Income From Discontinued Ops	-	-
Net Income	(19.1)	(10.4)
Net Income Attributable To Parent
Per Share
EPS Basic	(0.03)	(0.02)
EPS Diluted	-	-
Shares Basic	665.5	663.8
Shares Diluted	-	-
Supplementary Data
EBITDA	(34.8)	(24.2)
EBIT	(36.1)	(25.0)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Revenues
Revenues	548.5	630.2	838.0	426.4	356.1	228.0	204.9	214.1	241.2	216.1	178.2	87.3
Cost of Revenue	336.3	348.9	384.4	311.1	-	-	-	-	169.8	149.1	104.9	53.5
Gross Profit	212.2	281.3	453.6	115.3	-	-	-	-	71.4	66.9	73.3	33.9
Operating Expenses
Research & Development	148.3	212.1	302.0	386.9	299.1	174.8	138.2	114.2	75.5	66.9	47.4	29.9
Selling General & Administrative	-
Operating Income
Operating Income	(39.2)	(43.7)	18.4	(407.7)	(328.3)	(196.7)	(146.4)	(92.6)	(53.4)	(46.7)	(9.8)	(18.3)
Non-Operating
Interest Income	49.9	40.1	36.1	9.6	2.1	3.2	4.9	6.0	1.2	0.5	0.5	0.6
Interest Expense	2.9	2.9
Tax & Net
Income Tax Expense	63.6	7.2	4.5	(0.3)	11.9	4.8	3.3	4.0	3.1	4.3	1.6	1.3
Net Income From Continuing Ops	457.7
Per Share
EPS Basic	0.53	0.04	0.12	(0.43)	(0.25)	(0.18)	(0.16)	(0.11)	(0.04)	0.20	(0.64)	(0.62)
EPS Diluted	0.52	0.04
Supplementary Data
EBITDA	(25.9)	(31.4)	26.6	(399.0)	(321.1)	(190.6)	(141.4)	(89.1)	(50.8)	(44.4)	(7.8)	(17.0)
EBIT	(39.2)	(43.7)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)